| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amgen Inc (AMGN) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AMGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.2K | $174.14M | - | |
| VP | 83.4K | $28.74M | - | |
| VP | 51.2K | $17.66M | - | |
| CFO | 50.7K | $17.48M | - | |
| VP | 42.8K | $14.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | Williams R Sanders54 | Director | Sell | 250 | $237.99 | $59,497.50 | -5.1% | +7.1% | +4.6% | |
| Feb 4, 2021 | Graham Jonathan P | EVP, Gen. Counsel &Secy. | Sell | 11,110 | $236.51 | $2,627,624.99 | -21.8% | +5.7% | -3.6% | |
| Jan 13, 2021 | Sugar Ronald D | Director | Sale+OE | 1,000 | $235.99 | $235,990.00 | -6.0% | - | - | |
| Nov 9, 2020 | Williams R Sanders54 | Director | Sell | 250 | $242.40 | $60,600.00 | -4.8% | - | - | |
| Aug 19, 2020 | Sugar Ronald D | Director | Sale+OE | 1,000 | $241.02 | $241,020.00 | -6.0% | - | - | |
| Aug 7, 2020 | Williams R Sanders54 | Director | Sell | 250 | $242.95 | $60,737.50 | -4.6% | - | - | |
| Jul 22, 2020 | Sugar Ronald D | Director | Sale+OE | 1,000 | $259.79 | $259,790.00 | -6.0% | - | - | |
| Jun 17, 2020 | Sugar Ronald D | Director | Sale+OE | 1,000 | $228.54 | $228,540.00 | -6.0% | - | - | |
| May 20, 2020 | Sugar Ronald D | Director | Sale+OE | 1,000 | $229.27 | $229,270.00 | -6.1% | - | - | |
| May 6, 2020 | Williams R Sanders54 | Director | Sell | 425 | $237.31 | $100,856.75 | -7.3% | - | - |